Trial Profile
Assessment of the Reactogenicity of ADACEL (TdcP Vaccine) in Children and Adolescents 7 to 19 Years of Age
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Feb 2014
Price :
$35
*
At a glance
- Drugs DTaP vaccine (Primary)
- Indications Diphtheria; Pertussis; Tetanus
- Focus Adverse reactions
- Sponsors Sanofi
- 24 Sep 2008 Actual end date added as 1 Sep 2005 as reported by ClinicalTrials.gov.
- 24 Sep 2008 Actual initiation date added as 1 Sep 2004 as reported by ClinicalTrials.gov.
- 24 Sep 2008 Actual patient number is changed from 13238 to 7159 as reported by ClinicalTrials.gov.